Our results further indicated GPER1 acted as a protective factor in ESCA, KIRC, UCEC, BRCA and LUAD, but was only marginally statistically significant in BRCA and LUAD; in addition, GPER1 was involved in the modulation of immune microenvironment in NSCLC and its low expression could predict the likelihood that LUSC patients will benefit from treatment with ICIs.
← all excerpts
GPER1 is involved in shaping tumor immune microenvironment and its expression is decreased in NSCLC tumorigenesis.
1
—
—